Article metrics

Original research
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

 

Online download statistics by month:

Online download statistics by month: January 2022 to October 2022

AbstractFullPdf
Jan 2022894907314
Feb 2022734753339
Mar 2022611619315
Apr 2022587616298
May 2022548581279
Jun 202211833120241190
Jul 202253805455547
Aug 202225482583421
Sep 202232433313391
Oct 202217541792372
Total28132286434466